Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-11-022513
Filing Date
2011-04-27
Accepted
2011-04-26 18:36:45
Documents
5
Period of Report
2011-05-24
Effectiveness Date
2011-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a11-10911_2def14a.htm DEF 14A 533703
2 GRAPHIC g109112dai001.gif GRAPHIC 46771
3 GRAPHIC g109112dai002.gif GRAPHIC 35085
4 GRAPHIC g109112dai003.gif GRAPHIC 54809
5 GRAPHIC g109112dai004.gif GRAPHIC 44109
  Complete submission text file 0001104659-11-022513.txt   784536
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 11781231
SIC: 2834 Pharmaceutical Preparations